Kobayashi Healthcare International, Inc., 245 Kraft Dr. Dalton , GA 30721-1502 United StatesFEI 3003079019Issued Jan 27, 2023Office of Pharmaceutical Quality
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3003079019.
Violations4
Issue DateJan 27, 2023
Product TypeDrugs
StatusOpen
Letter Details
Firm
Kobayashi Healthcare International, Inc.
Location
Kobayashi Healthcare International, Inc., 245 Kraft Dr. Dalton , GA 30721-1502 United States
FEI Number
3003079019
Country
United States
Issue Date
January 27, 2023
Issuing Office
Office of Pharmaceutical Quality
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Kobayashi Healthcare International, Inc. FDA Warning Letter, January 27, 2023
Talk to a Specialist